Skip to main content

Plasma fibronectin in abdominal sepsis and shock: Therapeutic and prognostic value

  • Chapter
Book cover Schock

Part of the book series: Klinische Anästhesiologie und Intensivtherapie ((KAI,volume 33))

  • 17 Accesses

Abstract

>In recent years, two assumptions have led to a sustained interest in the role played by plasma fibronectin (Fn) in health and disease. The first is that plasma Fn serves as a critical regulator of reticuloendothelial system (RES) function; the second, that subnormal Fn levels are of clinical significance. The structure and known activities of Fn provide the basis for these concepts (reviewed in, 4, 11). Plasma fibronectin has been shown to bind to products of intravascular coagulation, cell debris, denatured and native collagens, and to some bacteria. Its interactions with macrophages, monocytes, and neutrophils facilitate the clearance of Fn-bound targets by the cells of the RES. The clearance promoting capabilities of Fn are, however, limited to the “target particles” to which Fn can bind, and by physiologic factors that are as yet incompletely understood (11). Animal studies have demonstrated a parallelism between Fn levels, RES function, and ultimate mortality following blunt tissue trauma; however, such associations are not found in states of thrombin induced DIC, experimental endotoxemia, gram-negative bacteremia and burns (reviewed in 11). Fn levels in these experimental settings do not necessarily reflect RES function nor perturbations in the complement, coagulation, fibrinolytic, or kinin generating systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Annest, S. J., Scovill, W. A., Blumenstock, F. A., Stratton, H. H., Newell, J. C., Paloski, W. H., Saba, T. M., Powers, S. R.: Increased creatinine clearance following cryoprecipitate infusion in trauma and surgical patients with decreased renal function. J. Trauma 20, 726 (1980)

    Article  PubMed  CAS  Google Scholar 

  2. Brodin, B.: Plasma fibronectin in septicaemia. A clinical study. Linkoeping University Medical Dissertations No. 169. Linkoeping, 1983

    Google Scholar 

  3. Brodin, B., Cedergren, B., Lieden, G., Malm, C., Strindberg, J., Vikrot, 0.: Prophylactic administration of cryoprecipi- tate to patients prone to develop fibronectin deficiency and septicemia. Abstracts of the 18th Congress of the International Society of Blood Transfusion. Munich July 22–27, 1984, p. 46, Basel: Karger 1984

    Google Scholar 

  4. Doran, J. E.: A critical assessment of fibronectin1s opsonic role for bacteria and microaggregates. Vox Sang. (Basel) 45, 337 (1983)

    CAS  Google Scholar 

  5. Doran, J. E., Callaway, B. D., Reese, A. C., Wynn, J. J., Mansberger Jr., A. R.: A competitive inhibition assay for gelatin binding fibronectin. Vox Sang. (Basel) 65, 243 (1983)

    Google Scholar 

  6. Doran, J. E., Mansberger, A. R., Reese, A. C.: Cold insoluble globulin-enhanced phagocytosis of gelatinized targets by macrophage monolayers: A model system. J. reticuloendothel. Soc. 21, 471 (1980)

    Google Scholar 

  7. Genestal, M., Sie, P., Hugot, B., Cathala, B., Boneu, B., Lareng, L.: Fibronectine plasmatique. Role dans l’infection sevère au reanimation. Presse Medicale 12, 1155 (1983)

    CAS  Google Scholar 

  8. Hesselvik, F., Brodin, B., Carlsson, C., Jorfeldt, L., Lieden, G., Cedergren, B.: Cryoprecipitate therapy in hyperdynamic septic shock - a controlled clinical study. Abstracts of the 18th Congress of the International Society of Blood Transfusion. Munich July 22–27, 1984, p. 46. Basel: Karger 1984

    Google Scholar 

  9. Lanser, M. E., Saba, T. M., Scovill, W. A.: Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis. Ann. Surg. 192., 776 (1980)

    Google Scholar 

  10. Lundsgaard-HANSEN, P., Doran, J. E., Rubli, E., Papp, E., Morgenthaler, J.-J., Spâth, P.: Purified fibronectin ad-ministration to patients with severe abdominal infections. A controlled clinical trial. Ann. Surg. 202, 79 (1985)

    Google Scholar 

  11. Lundsgaard-Hansen, P., Doran, J. E., Rubli, E.: Plasma fibronectin: Relevance for anesthesiology and intensive care. Intensive Care Med. (In press)

    Google Scholar 

  12. Robbins, A. B., Doran, J. E., Reese, A. C., Mansberger Jr., A. R.: Clinical response to cold insoluble globulin replacement in a patient with sepsis and thermal injury. Amer. J. Surg. 142, 636 (1981)

    Article  PubMed  CAS  Google Scholar 

  13. Rosner, B.: Fundamentals of biostatistics, p. 55–60. Boston: Duxbury Press 1982

    Google Scholar 

  14. Rubli, E., Bussard, S., Frei, E., Lundsgaard-Hansen, P., Pappova, E,: Plasma fibronectin and associated variables in surgical intensive care patients. Ann. Surg. 197, 310 (1983)

    Article  PubMed  CAS  Google Scholar 

  15. Saba, T. M., Blumenstock, F. A., Scovill, W. A., Bernhard, H.: Cryoprecipitate reversal of opsonic alpha2 surface binding glycoprotein deficiency in septic surgical and trauma patients. Science 201, 622 (1978)

    Article  PubMed  CAS  Google Scholar 

  16. Scovill, W. A., Saba, T. M., Blumenstock, F. A., Bernard, H., Powers, S. R.: Opsonic alpha2 surface binding glycoprotein therapy during sepsis. Ann. Surg. 188, 521 (1978)

    Article  PubMed  CAS  Google Scholar 

  17. Scovill, W, A., Annest, S. J., Saba, T. M., Blumenstock, F. A., Newell, J, C., Stratton, H. H., Powers, S. R.: Cardiovascular hemodynamics after opsonic alpha-2-surface binding glycoprotein therapy in injured patients. Surgery 86, 284 (T979)

    Google Scholar 

  18. Smith-Erichsen, N., Aasen, A. 0.: Evaluation of severity and prognosis in early stages of septicemia by means of chromogenic peptide substrate assays. Europ. surg. Res. 16, Suppl. 2, T40 (1984)

    Google Scholar 

  19. Smith-Erichsen, N., Aasen, A. O., Gallimore, M. J., Amundsen, E.: Studies of components of the coagulation system in normal individuals and septic shock patients. Circulat Shock 9, 491 (1982)

    CAS  Google Scholar 

  20. Snyder, E. L., Barash, P. G., Mosher, D. F., Walter, S. D Plasma fibronectin level and clinical status in cardiac surgery patients. J. Lab. clin. Med. 102, 881 (1983)

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Doran, J.E., Lundsgaard-Hansen, P. (1987). Plasma fibronectin in abdominal sepsis and shock: Therapeutic and prognostic value. In: Kilian, J., Meßmer, K., Ahnefeld, F.W. (eds) Schock. Klinische Anästhesiologie und Intensivtherapie, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72533-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72533-3_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17590-2

  • Online ISBN: 978-3-642-72533-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics